Core E: Prevention Science Core (PSC) Basic purposes of the core will be: 1) to develop and coordinate Prevention Science activities throughout the CFAR institutions, including Tufts and Brown Universities and the Fenway Community Health Center;2) to expand and coordinate CFAR Prevention Science activities in collaborating institutions in resource-restricted countries;3) to guide behavioral science activities throughout the CFAR;and 4) to assist in the training of local CFAR investigators and international Fogarty trainees in diagnostic techniques appropriate to the early diagnosis of HIV infection in both domestic and resource-restricted environments. Staff of the core will include Core Director Kenneth H. Mayer, MD, Professor of Medicine and Community Health at Brown Medical School. This core provides all Prevention and Education activities in this CFAR including the Fogarty AIDS International Research Training Program, HVTN, HPTN, and other Clinical Immunology Laboratory microbicide research. Dr. Mayer will provide advice on the prevention sciencerelated analysis performed in the Clinical Immunology Laboratory, which is directed by the Retrovirology Services Core (Core H). The laboratory is available for CFAR prevention science investigators to do assays on specimens from high-risk populations to obtain estimates of HIV incidence (e.g., measurement of antibody by the BED Capture assay, HIV RNA pooling, dried blot spot assays, and other serodiagnostic assays). Dr. Mayer will convene regular meetings of the Prevention Science Investigators to plan joint projects and review data generated by CFAR Prevention Science investigators. Lola Wright, the administrative coordinator of the PSC, will be responsible for meeting logistics and clerical/administrative support for Core investigators, as well as the focal person for information dissemination. Robert Ducharme is the PSC Research Associate who will assist investigators in developing new protocols, conducting qualitative interviews in hard-to-reach populations, and in collecting quantitative data for CFAR pilot studies, and performing HIV rapid testing for hard-to-reach populations. The Prevention Science Core will also coordinate the research collaborations with Fenway Community Health, which serves as a major component of the CFAR Prevention Science activities. Current HPTN and HVTN activities in the CFAR include bilateral collaborations between the Miriam Hospital and Fenway Community Health, including joint initiatives in community education and training in GCP for the conduct of NIH-funded clinical trials. The PSC will be responsible for the coordination of local prevention and behavioral research initiatives emanating from the new Clinical Trials Unit initiatives (i.e. HPTN, HVTN, MTN).

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-14
Application #
8320201
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
14
Fiscal Year
2011
Total Cost
$172,609
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Lee, Hana; Wu, Xiaotian K; Genberg, Becky L et al. (2018) Beyond binary retention in HIV care: predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort. AIDS 32:2217-2225
Whiteley, Laura B; Brown, Larry K; Curtis, Virginia et al. (2018) Publicly Available Internet Content as a HIV/STI Prevention Intervention for Urban Youth. J Prim Prev :
Sackey, Joachim; Zhang, Fang Fang; Rogers, Beatrice et al. (2018) Food security and dietary diversity are associated with health related quality of life after 6 months of follow up among people living with HIV in Accra, Ghana. AIDS Care 30:1567-1571
Rodriguez, Carla V; Rubenstein, Kevin B; Linas, Benjamin et al. (2018) Increasing hepatitis C screening in a large integrated health system: science and policy in concert. Am J Manag Care 24:e134-e140
Olney, Jack J; Eaton, Jeffrey W; Braitstein, Paula et al. (2018) Optimal timing of HIV home-based counselling and testing rounds in Western Kenya. J Int AIDS Soc 21:e25142
Gnatienko, Natalia; Freiberg, Matthew S; Blokhina, Elena et al. (2018) Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia. HIV Clin Trials 19:101-111
Brinkley-Rubinstein, Lauren; McKenzie, Michelle; Macmadu, Alexandria et al. (2018) A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend 184:57-63
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens. J Clin Virol 99-100:1-4
Lally, Michelle A; van den Berg, Jacob J; Westfall, Andrew O et al. (2018) HIV Continuum of Care for Youth in the United States. J Acquir Immune Defic Syndr 77:110-117
Schechter-Perkins, Elissa M; Miller, Nancy S; Hall, Jon et al. (2018) Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program. Acad Emerg Med :

Showing the most recent 10 out of 806 publications